These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 282006)

  • 1. Antitumor activity of interferon against murine osteogenic sarcoma in vitro and in vivo.
    Glasgow LA; Crane JL; Kern ER; Youngner JS
    Cancer Treat Rep; 1978 Nov; 62(11):1881-8. PubMed ID: 282006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of murine osteogenic sarcomas by treatment with type I or type II interferon.
    Crane JL; Glasgow LA; Kern ER; Youngner JS
    J Natl Cancer Inst; 1978 Sep; 61(3):871-4. PubMed ID: 278865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of interferon against murine osteogenic sarcoma cells in vitro.
    Glasgow LA; Crane JL; Kern ER
    J Natl Cancer Inst; 1978 Mar; 60(3):659-66. PubMed ID: 272470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antitumor effect of interferon against murine osteogenic sarcoma.
    Satomi H
    Nihon Seikeigeka Gakkai Zasshi; 1983 Feb; 57(2):199-213. PubMed ID: 6189927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo.
    Sayers TJ; Wiltrout TA; McCormick K; Husted C; Wiltrout RH
    Cancer Res; 1990 Sep; 50(17):5414-20. PubMed ID: 2117482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of interferon administration on pulmonary osteogenic sarcomas in an experimental murine model.
    Glasgow LA; Kern ER
    J Natl Cancer Inst; 1981 Jul; 67(1):207-12. PubMed ID: 6166780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fibroblast, lymphoid, and myeloid interferons on human tumor colony formation in vitro.
    Bradley EC; Ruscetti FW
    Cancer Res; 1981 Jan; 41(1):244-9. PubMed ID: 6160905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD3 + IL-2-stimulated murine killer cells. In vitro generation and in vivo antitumor activity.
    Anderson PM; Blazar BR; Bach FH; Ochoa AC
    J Immunol; 1989 Feb; 142(4):1383-94. PubMed ID: 2521662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New tumoricidal semisynthetic ether phospholipid, plasmanyl-(N-acyl)ethanolamine (PNAE(s)) and enhancement of its tumoricidal activity by calcium ions.
    Kára J; Konovalova AL; Krasnova MA; Liebl V; Bejsovcová L
    Neoplasma; 1993; 40(4):213-7. PubMed ID: 8272147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of growth of B16 murine malignant melanoma by exogenous interferon.
    Bart RS; Porzio NR; Kopf AW; Vilcek JT; Cheng EH; Farcet Y
    Cancer Res; 1980 Mar; 40(3):614-9. PubMed ID: 6162552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of combinations of interferons with tumor specific and nonspecific monoclonal antibodies as therapy for murine B- and T-cell lymphomas.
    Basham TY; Palladino MA; Badger CC; Bernstein ID; Levy R; Merigan TC
    Cancer Res; 1988 Aug; 48(15):4196-200. PubMed ID: 2455592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the primary in vitro antibody response by interferon preparations.
    Johnson HM; Smith BG; Baron S
    J Immunol; 1975 Jan; 114(1 Pt 2):403-9. PubMed ID: 1090660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral and cell multiplication inhibitory activities of mouse interferon poreparations tested on an interferon sensitive murine sarcoma cell line.
    Degré M
    Acta Pathol Microbiol Scand B; 1980 Aug; 88(4):219-23. PubMed ID: 6158254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage colony stimulating factor (CSF-1) blocks the myeloid suppressive but not the antiviral or antiproliferative activities of murine alpha, beta, and gamma interferons in vitro.
    Koren S; Klimpel GR; Fleischmann WR
    J Biol Response Mod; 1986 Dec; 5(6):571-80. PubMed ID: 2432191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal-like modulation of growth of moloney virus-induced tumors by interferon and platelet-derived growth factor.
    Inglot AD; Inglot O
    Arch Immunol Ther Exp (Warsz); 1983; 31(2):243-8. PubMed ID: 6197039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice.
    Heston WD; Fleischmann J; Tackett RE; Ratliff TL
    Cancer Res; 1984 Aug; 44(8):3220-5. PubMed ID: 6430546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types.
    Papa MZ; Mulé JJ; Rosenberg SA
    Cancer Res; 1986 Oct; 46(10):4973-8. PubMed ID: 3489517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-induced inhibition of Moloney sarcoma virus-transformed cells: requirement for T-cells.
    Skicki-Mullen MB; Markovic SN; Murasko DM
    Cancer Res; 1989 Feb; 49(3):522-7. PubMed ID: 2463077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Potentiation of chemotherapeutic activity by a Chinese herb medicine juzen-taiho-toh].
    Komiyama K; Hirokawa Y; Zhibo Y; Umezawa I; Hata T
    Gan To Kagaku Ryoho; 1988 May; 15(5):1715-9. PubMed ID: 3130806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collagen-production inhibitors evaluated as antitumor agents.
    Klohs WD; Steinkampf RW; Wicha MS; Mertus AE; Tunac JB; Leopold WR
    J Natl Cancer Inst; 1985 Aug; 75(2):353-9. PubMed ID: 3860688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.